Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study

Background: The present study aimed to examine the odds of cholangiocarcinoma (CCA) in patients with proton pump inhibitors (PPIs) use. Methods: A nested case-control study design was employed using data obtained from Taiwan's National Health Insurance Research Database. In total, 2,293 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yen-Chun, Lin, Cheng-Li, Hsu, Wan-Yun, Chow, Wai-Keung, Lee, Show-Wu, Yeh, Hong-Zen, Chen, Chia-Chang, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037835/
https://www.ncbi.nlm.nih.gov/pubmed/30018559
http://dx.doi.org/10.3389/fphar.2018.00718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037835/
https://www.ncbi.nlm.nih.gov/pubmed/30018559
http://dx.doi.org/10.3389/fphar.2018.00718

Ejemplares similares